Alan Mendelsohn serves as Executive at Timber Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Alan Mendelsohn has executed 3 insider transactions totaling $9.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 20, 2023 involved receiving (via award) 35,193 shares valued at $0.
Alan Mendelsohn currently holds 35,393 shares of Timber Pharmaceuticals, Inc. (TMBR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Mendelsohn has been a net buyer of TMBR stock. They have purchased $9.0K and sold $0 worth of shares.
Alan Mendelsohn's most recent insider trade was on Aug 20, 2023, when they sold 35,193 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.47 |
| Discretionary |
| Mar 3, 2021 | TMBR | $4.3K | Purchase | 1,988 | $2.17 | Discretionary |